Venrock

money flying in

Biotech

ADC biotech adds on $135M series B

TCGX led Adcendo's oversubscribed series B financing, with several existing investors—including RA Capital Management and Novo Holdings—in tow.

Gabrielle Masson Nov 25, 2024 7:00am

mountain top climb

Paragon spinout Apogee makes debut with $169M

Dec 7, 2022 6:30am

Ocelot

Ocelot Bio gets a cool $36M series A and a new CEO to boot

Mar 23, 2022 8:30am